J. Lipid Res. Please sign the JLR Guestbook
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cooper, A. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cooper, A. D.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Journal of Lipid Research, Vol 38, 2173-2192, Copyright © 1997 by Lipid Research, Inc.

REVIEWS

Hepatic uptake of chylomicron remnants

AD Cooper
Research Institute, Palo Alto Medical Foundation, CA 94301, USA.

Chylomicrons are formed in the intestine and transport dietary triglyceride to peripheral tissues and cholesterol to the liver. The enzyme lipoprotein lipase, with apolipoprotein (apo)C-II as a co- factor, hydrolyzes chylomicron triglyceride allowing the delivery of free fatty acids to muscle and adipose tissue. As a result, a new particle called a chylomicron remnant is formed. This particle is enriched in cholesteryl ester and fat-soluble vitamins and contains apoB-48 and apoE. It is rapidly removed from the circulation by the liver. ApoE is the moiety required for rapid hepatic removal. Its activity is inhibited by C apolipoproteins, especially apoC-I. Hepatic removal appears to be accomplished by several overlapping mechanisms. The particle must first achieve a size that allows it to be "sieved" through the endothelial fenestre allowing entrance into the space of Disse. Here, it may 1) be removed directly by LDL receptors; 2) acquire additional apoE that is secreted free into the space, and then be removed directly by the LDL receptor-related protein (LRP); or 3) it may be sequestered in the space. Sequestration occurs by binding of apoE to heparan sulfate proteoglycans and/or binding of apoB to hepatic lipase. Sequestered particles may be further metabolized allowing apoE, and lysophospholipid enrichment, followed by transfer to one of the above receptors for hepatic uptake. The above formulation is based upon animal studies. In humans, delayed removal of chylomicron remnants has been documented in diabetes, renal failure, and familial combined hyperlipemia and is the abnormality resulting in type III hyperlipidemia. Case control studies have identified delayed remnant removal as an independent risk factor for atherosclerotic cardiovascular disease. Thus, understanding the further details of the processes, and how it can be regulated in humans, is an important challenge for the future.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 Physiol. Rev.Home page
A. P. Lillis, L. B. Van Duyn, J. E. Murphy-Ullrich, and D. K. Strickland
LDL Receptor-Related Protein 1: Unique Tissue-Specific Functions Revealed by Selective Gene Knockout Studies
Physiol Rev, July 1, 2008; 88(3): 887 - 918.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
M. Altenburg, J. Arbones-Mainar, L. Johnson, J. Wilder, and N. Maeda
Human LDL Receptor Enhances Sequestration of ApoE4 and VLDL Remnants on the Surface of Hepatocytes but Not Their Internalization in Mice
Arterioscler. Thromb. Vasc. Biol., June 1, 2008; 28(6): 1104 - 1110.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
I. J. Goldberg, Y. Hu, H.-L. Noh, J. Wei, L. A. Huggins, M. G. Rackmill, H. Hamai, B. N. Reid, W. S. Blaner, and L.-S. Huang
Decreased Lipoprotein Clearance Is Responsible for Increased Cholesterol in LDL Receptor Knockout Mice With Streptozotocin-Induced Diabetes
Diabetes, June 1, 2008; 57(6): 1674 - 1682.
[Abstract] [Full Text] [PDF]

Home page
 Exp PhysiolHome page
V. Charlton-Menys and P. N. Durrington
Human cholesterol metabolism and therapeutic molecules
Exp Physiol, January 1, 2008; 93(1): 27 - 42.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
M. Guerin, W. Le Goff, E. Duchene, Z. Julia, T. Nguyen, T. Thuren, C. L. Shear, and M. J. Chapman
Inhibition of CETP by Torcetrapib Attenuates the Atherogenicity of Postprandial TG-Rich Lipoproteins in Type IIB Hyperlipidemia
Arterioscler. Thromb. Vasc. Biol., January 1, 2008; 28(1): 148 - 154.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
A. Pocathikorn, R. R. Taylor, I. James, and C. D. S. Mamotte
LDL-Receptor mRNA Expression in Men Is Downregulated within an Hour of an Acute Fat Load and Is Influenced by Genetic Polymorphism
J. Nutr., September 1, 2007; 137(9): 2062 - 2067.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
R. H. Nelson, D. S. Edgerton, R. Basu, J. C. Roesner, A. D. Cherrington, and J. M. Miles
Triglyceride Uptake and Lipoprotein Lipase-Generated Fatty Acid Spillover in the Splanchnic Bed of Dogs
Diabetes, July 1, 2007; 56(7): 1850 - 1855.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
J. Gao, H. Katagiri, Y. Ishigaki, T. Yamada, T. Ogihara, J. Imai, K. Uno, Y. Hasegawa, M. Kanzaki, T. T. Yamamoto, et al.
Involvement of Apolipoprotein E in Excess Fat Accumulation and Insulin Resistance
Diabetes, January 1, 2007; 56(1): 24 - 33.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
T. B. Cesar, M. R. M. Oliveira, C. H. Mesquita, and R. C. Maranhao
High Cholesterol Intake Modifies Chylomicron Metabolism in Normolipidemic Young Men
J. Nutr., April 1, 2006; 136(4): 971 - 976.
[Abstract] [Full Text] [PDF]

Home page
 J. Lipid Res.Home page
K. E. Kypreos and V. I. Zannis
LDL receptor deficiency or apoE mutations prevent remnant clearance and induce hypertriglyceridemia in mice
J. Lipid Res., March 1, 2006; 47(3): 521 - 529.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
H. N. Ginsberg
REVIEW: Efficacy and Mechanisms of Action of Statins in the Treatment of Diabetic Dyslipidemia
J. Clin. Endocrinol. Metab., February 1, 2006; 91(2): 383 - 392.
[Abstract] [Full Text] [PDF]

Home page
 J. Lipid Res.Home page
M. Asahina, M. Sato, and K. Imaizumi
Genetic analysis of diet-induced hypercholesterolemia in exogenously hypercholesterolemic rats
J. Lipid Res., October 1, 2005; 46(10): 2289 - 2294.
[Abstract] [Full Text] [PDF]

Home page
 DevelopmentHome page
B. Carpenter, Y. Lin, S. Stoll, R. L. Raffai, R. McCuskey, and R. Wang
VEGF is crucial for the hepatic vascular development required for lipoprotein uptake
Development, July 15, 2005; 132(14): 3293 - 3303.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
T. Linke, H. Dawson, and E. H. Harrison
Isolation and Characterization of a Microsomal Acid Retinyl Ester Hydrolase
J. Biol. Chem., June 17, 2005; 280(24): 23287 - 23294.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Clin. Nutr.Home page
C. Zhang, R. Lopez-Ridaura, E. B Rimm, N. Rifai, D. J Hunter, and F. B Hu
Interactions between the -514C->T polymorphism of the hepatic lipase gene and lifestyle factors in relation to HDL concentrations among US diabetic men
Am. J. Clinical Nutrition, June 1, 2005; 81(6): 1429 - 1435.
[Abstract] [Full Text] [PDF]

Home page
 J. Lipid Res.Home page
R. Out, M. Hoekstra, S. C. A. de Jager, P. de Vos, D. R. van der Westhuyzen, N. R. Webb, M. Van Eck, E. A. L. Biessen, and T. J. C. Van Berkel
Adenovirus-mediated hepatic overexpression of scavenger receptor class B type I accelerates chylomicron metabolism in C57BL/6J mice
J. Lipid Res., June 1, 2005; 46(6): 1172 - 1181.
[Abstract] [Full Text] [PDF]

Home page
 Postgrad. Med. J.Home page
G D Kolovou, K K Anagnostopoulou, and D V Cokkinos
Pathophysiology of dyslipidaemia in the metabolic syndrome
Postgrad. Med. J., June 1, 2005; 81(956): 358 - 366.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
A. Hamsten, A. Silveira, S. Boquist, R. Tang, M. G. Bond, U. de Faire, and J. Bjorkegren
The apolipoprotein CI content of triglyceride-rich lipoproteins independently predicts early atherosclerosis in healthy middle-aged men
J. Am. Coll. Cardiol., April 5, 2005; 45(7): 1013 - 1017.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
D. C. Chan, G. F. Watts, T. W.K. Ng, Y. Uchida, N. Sakai, S. Yamashita, and P. H. R. Barrett
Adiponectin and other Adipocytokines as Predictors of Markers of Triglyceride-Rich Lipoprotein Metabolism
Clin. Chem., March 1, 2005; 51(3): 578 - 585.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. Futamura, P. Dhanasekaran, T. Handa, M. C. Phillips, S. Lund-Katz, and H. Saito
Two-step Mechanism of Binding of Apolipoprotein E to Heparin: IMPLICATIONS FOR THE KINETICS OF APOLIPOPROTEIN E-HEPARAN SULFATE PROTEOGLYCAN COMPLEX FORMATION ON CELL SURFACES
J. Biol. Chem., February 18, 2005; 280(7): 5414 - 5422.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Clin. Nutr.Home page
B.-H. Chung, B. S. Cho, P. Liang, S. Doran, L. Osterlund, R. A Oster, B. Darnell, and F. Franklin
Contribution of postprandial lipemia to the dietary fat-mediated changes in endogenous lipoprotein-cholesterol concentrations in humans
Am. J. Clinical Nutrition, November 1, 2004; 80(5): 1145 - 1158.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
H. Wassef, L. Bernier, J. Davignon, and J. S. Cohn
Synthesis and Secretion of ApoC-I and ApoE during Maturation of Human SW872 Liposarcoma Cells
J. Nutr., November 1, 2004; 134(11): 2935 - 2941.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
H. L. Dichek, K. Qian, and N. Agrawal
Divergent Effects of the Catalytic and Bridging Functions of Hepatic Lipase on Atherosclerosis
Arterioscler. Thromb. Vasc. Biol., September 1, 2004; 24(9): 1696 - 1702.
[Abstract] [Full Text] [PDF]

Home page
 J. Lipid Res.Home page
B.-H. Chung, P. Liang, S. Doran, B. H. S. Cho, and F. Franklin
Postprandial chylomicrons: potent vehicles for transporting cholesterol from endogenous LDL+HDL and cell membranes to the liver via LCAT and CETP
J. Lipid Res., July 1, 2004; 45(7): 1242 - 1255.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
L. Quadro, L. Hamberger, M. E. Gottesman, V. Colantuoni, R. Ramakrishnan, and W. S. Blaner
Transplacental delivery of retinoid: the role of retinol-binding protein and lipoprotein retinyl ester
Am J Physiol Endocrinol Metab, June 1, 2004; 286(5): E844 - E851.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
R. Out, J. K. Kruijt, P. C. N. Rensen, R. B. Hildebrand, P. de Vos, M. Van Eck, and T. J. C. Van Berkel
Scavenger Receptor BI Plays a Role in Facilitating Chylomicron Metabolism
J. Biol. Chem., April 30, 2004; 279(18): 18401 - 18406.
[Abstract] [Full Text] [PDF]

Home page
 J. Lipid Res.Home page
H. L. Dichek, K. Qian, and N. Agrawal
The bridging function of hepatic lipase clears plasma cholesterol in LDL receptor-deficient "apoB-48-only" and "apoB-100-only" mice
J. Lipid Res., March 1, 2004; 45(3): 551 - 560.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
S. I. Malloy, M. K. Altenburg, C. Knouff, L. Lanningham-Foster, J. S. Parks, and N. Maeda
Harmful Effects of Increased LDLR Expression in Mice With Human APOE*4 But Not APOE*3
Arterioscler. Thromb. Vasc. Biol., January 1, 2004; 24(1): 91 - 97.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
T. Fu, K. F. Kozarsky, and J. Borensztajn
Overexpression of SR-BI by Adenoviral Vector Reverses the Fibrateinduced Hypercholesterolemia of Apolipoprotein E-deficient Mice
J. Biol. Chem., December 26, 2003; 278(52): 52559 - 52563.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
E S. Tai, D. Corella, M. Deurenberg-Yap, J. Cutter, S. K. Chew, C. E. Tan, and J. M. Ordovas
Dietary Fat Interacts with the -514C>T Polymorphism in the Hepatic Lipase Gene Promoter on Plasma Lipid Profiles in a Multiethnic Asian Population: The 1998 Singapore National Health Survey
J. Nutr., November 1, 2003; 133(11): 3399 - 3408.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Clin. Nutr.Home page
B.-H. Chung, S. Doran, P. Liang, L. Osterlund, B. S. Cho, R. A Oster, B. Darnell, and F. Franklin
Alcohol-mediated enhancement of postprandial lipemia: a contributing factor to an increase in plasma HDL and a decrease in risk of cardiovascular disease
Am. J. Clinical Nutrition, September 1, 2003; 78(3): 391 - 399.
[Abstract] [Full Text] [PDF]

Home page
 J. Lipid Res.Home page
K. G. Parhofer, E. Laubach, and P. H. R. Barrett
Effect of atorvastatin on postprandial lipoprotein metabolism in hypertriglyceridemic patients
J. Lipid Res., June 1, 2003; 44(6): 1192 - 1198.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
H. Saito, P. Dhanasekaran, D. Nguyen, F. Baldwin, K. H. Weisgraber, S. Wehrli, M. C. Phillips, and S. Lund-Katz
Characterization of the Heparin Binding Sites in Human Apolipoprotein E
J. Biol. Chem., April 18, 2003; 278(17): 14782 - 14787.
[Abstract] [Full Text] [PDF]

Home page
 Annals of Clinical & Laboratory ScienceHome page
H. Hidaka, M. Tozuka, B. Meyer, K. Yamauchi, M. Sugano, T. Nakabayashi, and T. Katsuyama
Characterization of Triglyceride Rich Lipoproteins with Very Light Density by Ultracentrifugation and Agarose Gel Electrophoresis using Triglyceride- and Cholesterol-Staining
Ann. Clin. Lab. Sci., April 1, 2003; 33(2): 167 - 178.
[Abstract] [Full Text] [PDF]

Home page
 ScienceHome page
G. Rudenko, L. Henry, K. Henderson, K. Ichtchenko, M. S. Brown, J. L. Goldstein, and J. Deisenhofer
Structure of the LDL Receptor Extracellular Domain at Endosomal pH
Science, December 20, 2002; 298(5602): 2353 - 2358.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
H. N. Ginsberg
New Perspectives on Atherogenesis: Role of Abnormal Triglyceride-Rich Lipoprotein Metabolism
Circulation, October 15, 2002; 106(16): 2137 - 2142.
[Full Text] [PDF]

Home page
 J. Lipid Res.Home page
Y. Kako, M. Masse, L.-S. Huang, A. R. Tall, and I. J. Goldberg
Lipoprotein lipase deficiency and CETP in streptozotocin-treated apoB-expressing mice
J. Lipid Res., June 1, 2002; 43(6): 872 - 877.
[Abstract] [Full Text] [PDF]

Home page
 J. Lipid Res.Home page
D. C. Chan, G. F. Watts, P. H. R. Barrett, I. J. Martins, A. P. James, J. C. L. Mamo, T. A. Mori, and T. G. Redgrave
Effect of atorvastatin on chylomicron remnant metabolism in visceral obesity: a study employing a new stable isotope breath test
J. Lipid Res., May 1, 2002; 43(5): 706 - 712.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
Z. Chen, R. L Fitzgerald, and G. Schonfeld
Hypobetalipoproteinemic Mice with a Targeted Apolipoprotein (Apo) B-27.6-specifying Mutation. IN VIVO EVIDENCE FOR AN IMPORTANT ROLE OF AMINO ACIDS 1254-1744 OF ApoB IN LIPID TRANSPORT AND METABOLISM OF THE ApoB-CONTAINING LIPOPROTEIN
J. Biol. Chem., April 12, 2002; 277(16): 14135 - 14145.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
R. L. Raffai and K. H. Weisgraber
Hypomorphic Apolipoprotein E Mice. A NEW MODEL OF CONDITIONAL GENE REPAIR TO EXAMINE APOLIPOPROTEIN E-MEDIATED METABOLISM
J. Biol. Chem., March 22, 2002; 277(13): 11064 - 11068.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
D. C. Chan, G. F. Watts, P. H. Barrett, J. C.L. Mamo, and T. G. Redgrave
Markers of Triglyceride-rich Lipoprotein Remnant Metabolism in Visceral Obesity
Clin. Chem., February 1, 2002; 48(2): 278 - 283.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
S. A. Schreyer, C. Vick, T. C. Lystig, P. Mystkowski, and R. C. LeBoeuf
LDL receptor but not apolipoprotein E deficiency increases diet-induced obesity and diabetes in mice
Am J Physiol Endocrinol Metab, January 1, 2002; 282(1): E207 - E214.
[Abstract] [Full Text] [PDF]

Home page
 Annals of Clinical & Laboratory ScienceHome page
H. Hidaka, M. Tozuka, E. Hidaka, K. Yamauchi, H. Ota, T. Honda, and T. Katsuyama
Characterization of an Apolipoprotein E3 Variant (Arg 145 -> His) Associated with Mild Hypertriglyceridemia
Ann. Clin. Lab. Sci., April 1, 2001; 31(2): 163 - 170.
[Abstract] [Full Text] [PDF]

Home page
 Exp. Biol. Med.Home page
E. Bravo, A. Cantafora, M. Avella, and K. M. Botham
Metabolism of Chylomicron Cholesterol Is Delayed by Estrogen. An In Vivo Study in the Rat
Experimental Biology and Medicine, February 1, 2001; 226(2): 112 - 118.
[Abstract] [Full Text]

Home page
 J. Nutr.Home page
R. Abia, Y. M. Pacheco, J. S. Perona, E. Montero, F. J. G. Muriana, and V. Ruiz-Gutiérrez
The Metabolic Availability of Dietary Triacylglycerols from Two High Oleic Oils during the Postprandial Period Does Not Depend on the Amount of Oleic Acid Ingested by Healthy Men
J. Nutr., January 1, 2001; 131(1): 59 - 65.
[Abstract] [Full Text]

Home page
 J. Lipid Res.Home page
K. C-W. Yu, Y. Jiang, W. Chen, and A. D. Cooper
Rapid initial removal of chylomicron remnants by the mouse liver does not require hepatically localized apolipoprotein E
J. Lipid Res., November 1, 2000; 41(11): 1715 - 1727.
[Abstract] [Full Text]

Home page
 J. Lipid Res.Home page
J. Dong, M. E. Balestra, Y. M. Newhouse, and K. H. Weisgraber
Human apolipoprotein E7: lysine mutations in the carboxy-terminal domain are directly responsible for preferential binding to very low density lipoproteins
J. Lipid Res., November 1, 2000; 41(11): 1783 - 1789.
[Abstract] [Full Text]

Home page
 J. Lipid Res.Home page
J. D. Medh, G. L. Fry, S. L. Bowen, S. Ruben, H. Wong, and D. A. Chappell
Lipoprotein lipase- and hepatic triglyceride lipase- promoted very low density lipoprotein degradation proceeds via an apolipoprotein E-dependent mechanism
J. Lipid Res., November 1, 2000; 41(11): 1858 - 1871.
[Abstract] [Full Text]

Home page
 RadiologyHome page
J. P. Weichert, F. T. Lee Jr, S. G. Chosy, M. A. Longino, J. E. Kuhlman, D. M. Heisey, and G. E. Leverson
Combined Hepatocyte-selective and Blood-Pool Contrast Agents for the CT Detection of Experimental Liver Tumors in Rabbits
Radiology, September 1, 2000; 216(3): 865 - 871.
[Abstract] [Full Text]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
A. M. Minihane, S. Khan, E. C. Leigh-Firbank, P. Talmud, J. W. Wright, M. C. Murphy, B. A. Griffin, and C. M. Williams
ApoE Polymorphism and Fish Oil Supplementation in Subjects With an Atherogenic Lipoprotein Phenotype
Arterioscler. Thromb. Vasc. Biol., August 1, 2000; 20(8): 1990 - 1997.
[Abstract] [Full Text] [PDF]

Home page
 J. Lipid Res.Home page
B. H. Chung and N. Dashti
Lipolytic remnants of human VLDL produced in vitro: effect of HDL levels in the lipolysis mixtures on the apoCs to apoE ratio and metabolic properties of VLDL core remnants
J. Lipid Res., February 1, 2000; 41(2): 285 - 297.
[Abstract] [Full Text]

Home page
 J. Nutr.Home page
R. Abia, J. S. Perona, Y. M. Pacheco, E. Montero, F. J. G. Muriana, and V. Ruiz-Gutiérrez
Postprandial Triacylglycerols from Dietary Virgin Olive Oil Are Selectively Cleared in Humans
J. Nutr., December 1, 1999; 129(12): 2184 - 2191.
[Abstract] [Full Text]

Home page
 J. Lipid Res.Home page
R. W. Mahley, Y. Huang, and S. C. Rall , Jr.
Pathogenesis of type III hyperlipoproteinemia (dysbetalipoproteinemia): questions, quandaries, and paradoxes
J. Lipid Res., November 1, 1999; 40(11): 1933 - 1949.
[Abstract] [Full Text]

Home page
 J. Biol. Chem.Home page
S. Swarnakar, R. E. Temel, M. A. Connelly, S. Azhar, and D. L. Williams
Scavenger Receptor Class B, Type I, Mediates Selective Uptake of Low Density Lipoprotein Cholesteryl Ester
J. Biol. Chem., October 15, 1999; 274(42): 29733 - 29739.
[Abstract] [Full Text] [PDF]

Home page
 J. Lipid Res.Home page
K. C-W. Yu, Y. Jiang, W. Chen, and A. D. Cooper
Evaluation of the components of the chylomicron remnant removal mechanism by use of the isolated perfused mouse liver
J. Lipid Res., October 1, 1999; 40(10): 1899 - 1910.
[Abstract] [Full Text]

Home page
 J. Lipid Res.Home page
N. Mero, L. Suurinkeroinen, M. Syvänne, P. Knudsen, H. Yki-Järvinen, and M.-R. Taskinen
Delayed clearance of postprandial large TG-rich particles in normolipidemic carriers of LPL Asn291Ser gene variant
J. Lipid Res., September 1, 1999; 40(9): 1663 - 1670.
[Abstract] [Full Text]

Home page
 Am. J. Clin. Nutr.Home page
C. T Phan, B.-C. Mortimer, I. J Martins, and T. G Redgrave
Plasma clearance of chylomicrons from butterfat is not dependent on saturation: studies with butterfat fractions and other fats containing triacylglycerols with low or high melting points
Am. J. Clinical Nutrition, June 1, 1999; 69(6): 1151 - 1161.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
F. T. Yen, M. Masson, N. Clossais-Besnard, P. Andre, J.-M. Grosset, L. Bougueleret, J.-B. Dumas, O. Guerassimenko, and B. E. Bihain
Molecular Cloning of a Lipolysis-stimulated Remnant Receptor Expressed in the Liver
J. Biol. Chem., May 7, 1999; 274(19): 13390 - 13398.
[Abstract] [Full Text] [PDF]

Home page
 J. Lipid Res.Home page
S. E. Crawford and J. Borensztajn
Plasma clearance and liver uptake of chylomicron remnants generated by hepatic lipase lipolysis: evidence for a lactoferrin-sensitive and apolipoprotein E-independent pathway
J. Lipid Res., May 1, 1999;